Hyperphosphatemia Market Set for Robust Growth During the Forecast Period (2026-2036), Driven by Novel Therapeutics and Rising CKD Burden | DelveInsight
The hyperphosphatemia market is projected to witness steady growth, driven by the increasing global prevalence of chronic kidney disease, diabetes, and hypertension, along with a growing dialysis patient population. Additionally, the emergence of novel therapies such as TS-172 (Taisho...
Read the full story on PR Newswire → Opens the original article on www.prnewswire.comSummary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.